A carregar...

Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD(8)(+) CTL-mediated cytotoxicity in HLA-A2(+) human PBMCs

AIM: To explore how to improve the immunogenicity of HBcAg CTL epitope based polypeptides and to trigger an HBV-specific HLA I-restricted CD(8)(+) T cell response in vitro. METHODS: A new panel of mimetic therapeutic peptides based on the immunodominant B cell epitope of HBV PreS2 18-24 region, the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Shi, Tong-Dong, Wu, Yu-Zhang, Jia, Zheng-Cai, Zou, Li-Yun, Zhou, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2004
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4572227/
https://ncbi.nlm.nih.gov/pubmed/15222033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i13.1902
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!